Found: 12
Select item for more details and to access through your institution.
CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.3_2880
- By:
- Publication type:
- Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
- By:
- Publication type:
- Article
PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULATORY THERAPY CRITERIA (LYRIC) IN GATA TRIAL FROM THE LYSA GROUP.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.157_2880
- By:
- Publication type:
- Article
IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO-RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END-POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 72, doi. 10.1002/hon.2437_59
- By:
- Publication type:
- Article
THE 5-YEAR FOLLOW-UP RESULTS OF THE C5R PROTOCOL WITH RITUXIMAB AND INTRATHECAL LIPOSOMAL CYTARABINE FOR PRIMARY CNS LYMPHOMA: A PROSPECTIVE PHASE 2 STUDY OF THE LYSA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 198, doi. 10.1002/hon.2438_61
- By:
- Publication type:
- Article
TUMOR GENOMIC COPY NUMBER ABNORMALITIES ANALYZED BY HIGH RESOLUTION SNP ARRAY IMPACT OUTCOME OF PRIMARY CNS LYMPHOMA: A RETROSPECTIVE ANALYSIS ON 68 PATIENTS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 160, doi. 10.1002/hon.2438_16
- By:
- Publication type:
- Article
MINIMAL RESIDUAL DISEASE AND OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) IN THE PHASE III GADOLIN TRIAL OF OBINUTUZUMAB AND BENDAMUSTINE VS BENDAMUSTINE.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 216, doi. 10.1002/hon.2438_80
- By:
- Publication type:
- Article
CAUSE OF DEATH IN FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: A POOLED ANALYSIS OF FRENCH AND US COHORTS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 34, doi. 10.1002/hon.2437_15
- By:
- Publication type:
- Article
ROLE OF UP-FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T-CELL LYMPHOMAS: a PROPENSITY SCORE MATCHING ANALYSIS OF PATIENTS FROM LYSA CENTERS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 76, doi. 10.1002/hon.2437_64
- By:
- Publication type:
- Article
A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B-CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 52, doi. 10.1002/hon.2437_36
- By:
- Publication type:
- Article
Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1144, doi. 10.1007/s00259-020-05015-2
- By:
- Publication type:
- Article